These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L. Lv L, Li Q, Chen S, Zhang X, Tao X, Tang X, Wang S, Che G, Yu Y, He L. Exp Cell Res; 2019 Dec 01; 385(1):111597. PubMed ID: 31525340 [Abstract] [Full Text] [Related]
3. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer. Sun W, Li J, Zhou L, Han J, Liu R, Zhang H, Ning T, Gao Z, Liu B, Chen X, Ba Y. Theranostics; 2020 Dec 01; 10(5):1981-1996. PubMed ID: 32104496 [Abstract] [Full Text] [Related]
4. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y, Jia L. Mol Carcinog; 2017 Dec 01; 56(12):2669-2680. PubMed ID: 28767179 [Abstract] [Full Text] [Related]
5. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer. Feng C, Zhang L, Sun Y, Li X, Zhan L, Lou Y, Wang Y, Liu L, Zhang Y. Biomed Pharmacother; 2018 May 01; 101():945-952. PubMed ID: 29635904 [Abstract] [Full Text] [Related]
6. High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer. Rasmussen MH, Jensen NF, Tarpgaard LS, Qvortrup C, Rømer MU, Stenvang J, Hansen TP, Christensen LL, Lindebjerg J, Hansen F, Jensen BV, Hansen TF, Pfeiffer P, Brünner N, Ørntoft TF, Andersen CL. Mol Oncol; 2013 Jun 01; 7(3):637-46. PubMed ID: 23506979 [Abstract] [Full Text] [Related]
8. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells. Ren T, Hou J, Liu C, Shan F, Xiong X, Qin A, Chen J, Ren W. Biomed Pharmacother; 2019 Sep 01; 117():109171. PubMed ID: 31261026 [Abstract] [Full Text] [Related]
9. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1. Liu X, Xie T, Mao X, Xue L, Chu X, Chen L. Cell Physiol Biochem; 2016 Sep 01; 39(2):617-29. PubMed ID: 27415661 [Abstract] [Full Text] [Related]
10. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1. Liu H, Yin Y, Hu Y, Feng Y, Bian Z, Yao S, Li M, You Q, Huang Z. Pathol Res Pract; 2016 Jul 01; 212(7):643-9. PubMed ID: 27173050 [Abstract] [Full Text] [Related]
11. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression. Zhou H, Lin C, Zhang Y, Zhang X, Zhang C, Zhang P, Xie X, Ren Z. Cell Prolif; 2017 Jun 01; 50(3):. PubMed ID: 28217977 [Abstract] [Full Text] [Related]
12. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4. Azar MRMH, Aghazadeh H, Mohammed HN, Sara MRS, Hosseini A, Shomali N, Tamjidifar R, Tarzi S, Mansouri M, Sarand SP, Marofi F, Akbari M, Xu H, Shotorbani SS. Int Immunopharmacol; 2021 Mar 01; 92():107355. PubMed ID: 33429333 [Abstract] [Full Text] [Related]
13. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis. Jiang S, Miao D, Wang M, Lv J, Wang Y, Tong J. J Cell Mol Med; 2019 Jan 01; 23(1):630-640. PubMed ID: 30338942 [Abstract] [Full Text] [Related]
14. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling. Jin Y, Wang M, Hu H, Huang Q, Chen Y, Wang G. Int J Biol Macromol; 2018 Oct 01; 117():445-453. PubMed ID: 29852230 [Abstract] [Full Text] [Related]
15. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Zhou Y, Wan G, Spizzo R, Ivan C, Mathur R, Hu X, Ye X, Lu J, Fan F, Xia L, Calin GA, Ellis LM, Lu X. Mol Oncol; 2014 Feb 01; 8(1):83-92. PubMed ID: 24145123 [Abstract] [Full Text] [Related]
16. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo. Yang S, Li W, Sun H, Wu B, Ji F, Sun T, Chang H, Shen P, Wang Y, Zhou D. BMC Cancer; 2015 Dec 16; 15():969. PubMed ID: 26674205 [Abstract] [Full Text] [Related]
17. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer. Xu F, Ye ML, Zhang YP, Li WJ, Li MT, Wang HZ, Qiu X, Xu Y, Yin JW, Hu Q, Wei WH, Chang Y, Liu L, Zhao Q. Cancer Sci; 2020 May 16; 111(5):1528-1541. PubMed ID: 32073706 [Abstract] [Full Text] [Related]
18. Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment. Kjersem JB, Ikdahl T, Lingjaerde OC, Guren T, Tveit KM, Kure EH. Mol Oncol; 2014 Feb 16; 8(1):59-67. PubMed ID: 24119443 [Abstract] [Full Text] [Related]
19. Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance. Jiang Z, Hou Z, Liu W, Yu Z, Liang Z, Chen S. Bioengineered; 2022 Jan 16; 13(1):810-823. PubMed ID: 34974791 [Abstract] [Full Text] [Related]
20. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer. Yu X, Shi W, Zhang Y, Wang X, Sun S, Song Z, Liu M, Zeng Q, Cui S, Qu X. Sci Rep; 2017 Feb 08; 7():42226. PubMed ID: 28176874 [Abstract] [Full Text] [Related] Page: [Next] [New Search]